Emmanuel Guardiola
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Intraperitoneal and Appendiceal Malignancies, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial(2021)145 cited
- → Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer(2004)117 cited
- → Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial(2018)69 cited
- → Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?(2004)61 cited
- → The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy(2001)59 cited
- → Concomitant twice‐a‐day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long‐term quality of life analysis(2001)58 cited
- → Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer(2005)52 cited
- → Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients(2017)46 cited
- → Phase I and pharmacokinetic study of the association of capecitabine–cisplatin in head and neck cancer patients(2003)46 cited
- → Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding(2005)45 cited